Margit Focke-Tejkl

13PUBLICATIONS
78CO-AUTHORS
AllergyNon-genetically modified uses of biotechnologyNanomedicineApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Food packaging, preservation and processing
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Aug 13, 2026
IgE Occupancy and Antigen Valency Cooperate to Control FcεRI Aggregation Geometry and Signaling Efficiency.

|Feb 04, 2026
Microarrayed Allergen Molecules Distinguish IgE Sensitisation to Blomia tropicalis and Dermatophagoides pteronyssinus.

Nishelle Dsouza, Siratcha Phanthong, Huey-Jy Huang

|Oct 26, 2024
The PreS-Based Recombinant Vaccine VVX001 Induces Hepatitis B Virus Neutralizing Antibodies in a Low-Responder to HBsAg-Based HBV Vaccines.

Inna Tulaeva, Felix Lehmann, Nora Goldmann

|Mar 28, 2024
Vaccine Based on Recombinant Fusion Protein Combining Hepatitis B Virus PreS with SARS-CoV-2 Wild-Type- and Omicron-Derived Receptor Binding Domain Strongly Induces Omicron-Neutralizing Antibodies in a Murine Model.

Pia Gattinger, Bernhard Kratzer, Al Nasar Ahmed Sehgal

|Mar 13, 2024
Coupling of a Major Allergen to the Surface of Immune Cells for Use in Prophylactic Cell Therapy for the Prevention of IgE-Mediated Allergy.

Konstantinos Mengrelis, Gerhard Niederacher, Lisa Prickler

|Sep 28, 2023
Monomeric agonist peptide/MHCII complexes activate T-cells in an autonomous fashion.

René Platzer, Joschka Hellmeier, Janett Göhring

Pageof 3

Frequent Collaborators

5 joint publications

Rudolf Valenta

3 joint publications

Inna Tulaeva

2 joint publications

Milena Weber

2 joint publications

Susanne Vrtala